Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pediatrics
Volume 2016, Article ID 4328492, 5 pages
http://dx.doi.org/10.1155/2016/4328492
Case Report

Anterior Hypopituitarism and Treatment Response in Hunter Syndrome: A Comparison of Two Patients

1Department of Pediatrics, University of Saskatchewan, Royal University Hospital, 103 Hospital Drive, Saskatoon, SK, Canada
2Section of Pediatric Endocrinology, University of Calgary, Alberta Children’s Hospital, 2888 Shaganappi Trail NW, Calgary, AB, Canada
3Department of Diagnostic Imaging, University of Calgary, Alberta Children’s Hospital, Calgary, AB, Canada
4Departments of Medical Genetics and Pediatrics, University of Calgary, Alberta Children’s Hospital, 2888 Shaganappi Trail NW, Calgary, AB, Canada

Received 4 August 2016; Revised 14 October 2016; Accepted 24 October 2016

Academic Editor: Tarak Srivastava

Copyright © 2016 Munier A. Nour et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Nelson and D. Carson, “Pituitary function studies in a case of mild Hunter's syndrome (MPS IIB),” Journal of Medical Genetics, vol. 26, no. 11, pp. 731–732, 1989. View at Publisher · View at Google Scholar · View at Scopus
  2. S. P. Toledo, V. H. Costa, R. R. Fukui, and N. Abelin, “Serum growth hormone levels in Hunter's syndrome,” Revista do Hospital das Clinicas de Faculdade de Medicina da Universidade de Sao Paulo, vol. 46, no. 1, pp. 9–13, 1991. View at Google Scholar · View at Scopus
  3. I. D. Young and P. S. Harper, “Mild form of Hunter's syndrome: clinical delineation based on 31 cases,” Archives of Disease in Childhood, vol. 57, no. 11, pp. 828–836, 1982. View at Publisher · View at Google Scholar · View at Scopus
  4. Center for Disease Control, CDC Growth Charts for the United States, Public Health Service, Centers for Disease Control and Prevention, National Center for Health Statistics, Hyattsville, Md, USA, 2002.
  5. J. E. Wraith, M. Scarpa, M. Beck et al., “Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy,” European Journal of Pediatrics, vol. 167, no. 3, pp. 267–277, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. S. J. Chen, Y. W. Li, T. R. Wang, and J. C. Hsu, “Bony changes in common mucopolysaccharidoses,” Zhonghua Minguo xiao er ke yi xue hui za zhi. Zhonghua Minguo xiao er ke yi xue hui, vol. 37, no. 3, pp. 178–184, 1996. View at Google Scholar · View at Scopus
  7. V. J. Parsons, D. G. Hughes, and J. E. Wraith, “Magnetic resonance imaging of the brain, neck and cervical spine in mild Hunter’s syndrome (mucopolysaccharidoses type II),” Clinical Radiology, vol. 51, pp. 719–723, 1996. View at Google Scholar
  8. K. E. Von Mühlendahl and G. B. Bradac, “Empty sella syndrome in a boy with mucopolysaccharidosis type VI (Maroteaux-Lamy),” Helvetica Paediatrica Acta, vol. 30, no. 2, pp. 185–190, 1975. View at Google Scholar · View at Scopus
  9. B. Büyükgebiz, Y. Eroğlu, I. Kovanlikaya, A. Sen, and A. Buyukgebiz, “Maroteaux-Lamy syndrome associated with growth hormone deficiency,” Journal of Pediatric Endocrinology and Metabolism, vol. 8, no. 4, pp. 305–307, 1995. View at Google Scholar · View at Scopus
  10. K. Nagashima, H. Endo, K. Sakakibara et al., “Morphological and biochemical studies of a case of mucopolysaccharidosis II (Hunter's syndrome),” Acta Pathologica Japonica, vol. 26, no. 1, pp. 115–132, 1976. View at Google Scholar · View at Scopus
  11. H. Oda, Y. Sasaki, Y. Nakatani, H. Maesaka, and S. Suwa, “Hunter's syndrome. An ultrastructural study of an autopsy case,” Acta Pathologica Japonica, vol. 38, no. 9, pp. 1175–1190, 1988. View at Google Scholar · View at Scopus
  12. L. E. Polgreen and B. S. Miller, “Growth patterns and the use of growth hormone in the mucopolysaccharidoses,” Journal of Pediatric Rehabilitation Medicine, vol. 3, no. 1, pp. 25–38, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. L. E. Polgreen, W. Thomas, P. J. Orchard, C. B. Whitley, and B. S. Miller, “Effect of recombinant human growth hormone on changes in height, bone mineral density, and body composition over 1-2years in children with Hurler or Hunter syndrome,” Molecular Genetics and Metabolism, vol. 111, no. 2, pp. 101–106, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. L. E. Polgreen, M. Plog, J. D. Schwender et al., “Short-term growth hormone treatment in children with Hurler syndrome after hematopoietic cell transplantation,” Bone Marrow Transplantation, vol. 44, no. 5, pp. 279–285, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Parini, S. A. Jones, P. R. Harmatz, R. Giugliani, and N. J. Mendelsohn, “The natural history of growth in patients with Hunter syndrome: data from the Hunter Outcome Survey (HOS),” Molecular Genetics and Metabolism, vol. 117, no. 4, pp. 438–446, 2016. View at Publisher · View at Google Scholar
  16. S. A. Jones, R. Parini, P. Harmatz, R. Giugliani, J. Fang, and N. J. Mendelsohn, “The effect of idursulfase on growth in patients with Hunter syndrome: data from the Hunter Outcome Survey (HOS),” Molecular Genetics and Metabolism, vol. 109, no. 1, pp. 41–48, 2013. View at Publisher · View at Google Scholar · View at Scopus